This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Scripps Research Institute. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: The Innovative Contributions of Philip LoGrasso
Introduction
Philip LoGrasso is a notable inventor based in Jupiter, FL (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of protein kinase inhibitors. With a total of 2 patents to his name, his work has the potential to impact various medical treatments.
Latest Patents
LoGrasso's latest patents focus on novel substituted pyrimidinyl-amines that serve as inhibitors of protein kinases. These compounds are especially effective against c-Jun N-terminal kinases (JNK). The inventions provide pharmaceutical compositions and methods for treating conditions that respond to the inhibition of the JNK pathway. This innovative approach could lead to advancements in therapies for various diseases.
Career Highlights
Philip LoGrasso is affiliated with the Scripps Research Institute, where he conducts his research and development. His work is characterized by a commitment to advancing medical science through innovative solutions. His contributions have been recognized within the scientific community, showcasing his expertise in the field.
Collaborations
LoGrasso has collaborated with esteemed colleagues such as Rong Jiang and Xinyi Song. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Philip LoGrasso's innovative work in the field of protein kinase inhibitors exemplifies the impact of dedicated research on medical advancements. His contributions continue to pave the way for new therapeutic options.